Nevertheless, clinically, the expression levels of TSHR seem to be downregulated in patients with more advanced stages of thyroid cancer, especially for those with poorly differentiated cell types, suggesting the existence of an uncharacterized selection/adaption mechanism [103]. This evidence concerns the gene TSHR and thyroid gland carcinoma.